Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04736667 · ClinicalTrials.gov registry record

Mitral Valve Screening Survey

A clinical trial of Mitral Valve Disease, sponsored by Medstar Health Research Institute.

Recruiting
Registry status
1,000
Enrollment target
16
Study locations

NCT04736667 is a study of Mitral Valve Disease that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 1,000 participants, above the 256-participant average among 5 other Mitral Valve Disease trials with a reported enrollment target (291% higher). The trial reports 16 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04736667, a study of Mitral Valve Disease, is actively recruiting participants, sponsored by Medstar Health Research Institute.

RECRUITING
Registry status
1,000 participants
Enrollment target
16
Study locations

Study Summary

This study aims to examine the clinical profile/anatomical characteristics and natural history of patients who subsequently fail screening for transcatheter mitral valve intervention (TMVI).

Conditions Studied

Study Locations (16)

Florida

  • Morton Plant Hospital - Clearwater
  • HealthPark Medical Center - Fort Myers

Arizona

  • Phoenix Cardiovascular Research Group - Phoenix

California

  • Keck Hospital of USC - Los Angeles

District of Columbia

  • MedStar Washington Hospital Center - Washington D.C.

Illinois

  • Northwestern University - Chicago

Iowa

  • MercyOne Iowa Heart Center - West Des Moines

Kansas

  • University of Kansas Medical Center - Kansas City

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2021-08-06
Est. Completion 2027-02

Sponsor

Medstar Health Research Institute

115 total trials

What the Registry Record Tells You About NCT04736667

The ClinicalTrials.gov registry entry for NCT04736667 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 256-participant average among 5 other Mitral Valve Disease trials with a reported enrollment target (291% higher). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mitral Valve Disease appearing as the primary indexed condition, and to 0 interventions.

NCT04736667 reports 16 study locations spanning 15 distinct geographic areas - top geographies include Florida, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT04736667 about?

NCT04736667 is a clinical study titled "Mitral Valve Screening Survey". This study aims to examine the clinical profile/anatomical characteristics and natural history of patients who subsequently fail screening for transcatheter mitral valve intervention (TMVI).

What is the current status of trial NCT04736667?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2021-08-06. Estimated completion is 2027-02.

What conditions does trial NCT04736667 study?

This clinical trial studies the following conditions: Mitral Valve Disease.

Who is sponsoring clinical trial NCT04736667?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04736667 being conducted?

This trial has 16 study locations across Arizona, California, District of Columbia, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mitral Valve Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.